FDA Investigator Ko U Min

Ko U Min has conducted inspections on 27 sites in 3 countries as of 19 Dec 2022. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
27
Last Inspection Date:
19 Dec 2022
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, Italy
FDA Investigators that have inspected at least one site in common with Ko U Min:
Addam S Reynolds, Adetutu M Gidado, Aditi S Thakur, Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amy L Singer, Amy M Cramer, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Anita Narula, PhD, Anita R Michael, Ankur C Patel, Annemarie Bodnar, Anthony A Charity, Atul J Agrawal, Audrey Thereset Uy, Barbara A Gullick, Barbara Jwilimczyk Macri, Bijoy Panicker, Brandy N Lepage, Brooke K Higgins, Brooke K Seeman, Bryan L Mcguckin, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charles Yuanchia Kuo, PhD, Chiang Syin, PhD, Chiaochun J Wang, Christina K Theodorou, Christopher R Czajka, Craig D Zagata, Crystal Monroy, Cynthia A Palmer, Daniel J Grabicki, Daniel J Lahar, Daniel J Min, Daniel L Zheng, David A Oluwo, Dawn L Wydner, Debra J Bennett, Debra L Pagano, Denise M Digiulio, Dennis L Doupnik, Diane T Bargo, Diane T O'brien, Dorothy J Denes, Douglas A Campbell, Douglas C Kovacs, Dr. Dominick Roselle, Dr. Robert C Horan, MD, Dr. Roslyn F Powers, Dr. Yubing Tang, Dr. Zhihao Qiu (Peter), PhD, Edmund F Mrak, Jr, Emest F Bizjak, Emmanuel Jramos Maldonado, Erika V Butler, Frederick F Razzaghi, Gayle S Lawson, George Lunn, PhD, George Pyramides, Gloria J Baca, MS, Grace I Cortesini, Guerlain Ulysse, Hala L Selby, Hala Lj Whetstone, Hector A Carrero, Hector Jcolon Torres, Helen B Ricalde, Helen Verdel, Himanshu Gupta, PhD, Huiquan Wu, Hung H Do, MS, Ivis L Negron, James L Dunnie, Jr, James M Mason, James M Simpson, James R Birkenstamm, Janet A Rajan, Jay B Shah, Jogy George, John P Mistler, Johnna L Bleem, Jonah S Ufferfilge, Jonathan W Chapman, Jose Acruz Gonzalez, Jose M Cayuela, Jose Ohernandez Guzman, Jose R Hernandez, Joseph F Mcginnis, RPh, Joseph W Matthews, Joy Rkozlowski Klena, Julianne C Mccullough, Junho Pak, Justine Tomasso, Karen A Briggs, Karen E D'orazio, Karishma G Gopaul, Katelyn Astaub Zamperini, Katherine Szestypalow, Kathleen M Jordan, Kelli F Dobilas, Kendra L Brooks, Kenneth M Gordon, Kenneth Nieves, Kevin P Foley, Kristen D Evans, Kristina L Conroy, Kshitij A Patkar, Kurt A Brorson, PhD, Lance Mde Souza, MBA, Lata C Mathew, PhD, Lauren L Vajo, Lawrence Harmon, Jr, Lawrence J Stringer, Leiyun Boone, PhD, Liatte Kreuger, PharmD, Linda M Hoover, Lisa K Capron, Lisa M Bellows, Lori S Lawless, Luis A Dasta, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcus A Ray, Marea K Harmon, Margaret M Doherty, Margaret M Sands, Maria A Reed, Maria Estrella, Marijo B Kambere, PhD, Marlene G Swider, Massoud Motamed, Matthew M Henciak, Meena Bansal Gupta, PhD, Melissa J Garcia, Melissa T Roy, Meyer J Slobotsky, Michael A Taylor, Michael Gurbarg, Michael L Casner, Michael R Goga, Michael R Klapal, Michael Shanks, MS, Michele Gottshall, Michele M Falchek, Michelle Marsh, Mindy M Chou, Monika Borkowska, Nailing Zhang, Nancy F Scheraga, Nancy M Espinal, Nataniel Phillips Sylvain, PhD, Natasha Gupta, Nebil A Oumer, Nicholas A Violand, Nicholas L Hunt, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Paul L Bellamy, Paula J Bretz, Prabhu P Raju, Pratik S Upadhyay, DDC, Qin Xu, Rabin N Ghoshal, Rachael O Oyewole, Rachel C Harrington, Rebecca E Dombrowski, Regina T Brown, Richard E Needham, Robert B Shibuya, MD, Robert D Tollefsen, Robert J Maffei, Robert J Martin, Russell J Glapion, Saleem A Akhtar, Sam Pepe, Samuel Mindaye, Sandra A Boyd, Sarah Adella Fave, Sean R Marcsisin, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shirley J Berryman, Shirley S Wen, Shirshendu K Deb, PhD, Simone E Pitts, Sneha S Patel, Sony Mathews, Sridhar Thumma, Srinivas R Chennamaneni, PhD, Stephanie Mangigian, MS/OSH, RN, Stephen J Koniers, Suchan Kim, Susan F Laska, MS, Syeda N Mahazabin, Tamika White, Tamil Arasu, PhD, Tammy L Chavis, Temar Q Williams, Thomas E Friel, Thomas J Arista, Thuy T Nguyen, LCDR, Tiffani D Wilson, Todd J Maushart, Tonia F Bernard, Toyin B Oladimeji, Tracy K Li, Unnee Ranjan, Valerie L Whipp, Viviana Matta, Vivin George, Vlada Matusovsky, Walter L Fava, Wanda Y Honeyblue, Wayne E Seifert, William A Warnick, William L Bargo, Yan Wang, Yong Wu, PhD, Yvesna C Blaise, Yvins Dezan, Zachary A Bogorad, Zhongren Wu

Ko U Min's Documents

Publish Date Document Type Title
November, 2020 FDA 483 Novel Laboratories, Inc. - Form 483, 2020-11-05
August, 2022 FDA 483 A.P. Deauville, LLC - Form 483, 2022-08-25
May, 2022 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2022-06-22
June, 2021 FDA 483 Carnegie Pharmaceuticals, LLC - Form 483, 2021-06-29
April, 2015 FDA 483 WuXi Advanced Therapies Inc. - Form 483, 2015-04-17
June, 2018 FDA 483 Advanced Accelerator Applications (Italy) S.r.l. - Form 483, 2018-06-08
May, 2017 FDA 483 Pharmaceutical Manufacturing Research Services, Inc. - Form 483, 2017-05-25
April, 2018 FDA 483 Mylan Pharmaceuticals Inc. - Form 483, 2018-04-12
July, 2017 FDA 483 Lonza Bend Inc. - Form 483, 2017-07-21
February, 2022 FDA 483 Guardian Drug Company - Form 483, 2022-02-17
August, 2020 FDA 483 ImClone Systems LLC - Form 483, 2020-08-21
November, 2020 FDA 483 Response Novel Laboratories, Inc. - Form 483R, 2020-11-05
August, 2020 FDA 483 Response ImClone Systems LLC - Form 483R, 2020-09-14
May, 2021 FDA 483 SAMJAN GROUP INC. (DBA PLS Analytical) - Form 483, 2021-05-28
March, 2022 FDA 483 Novel Laboratories, Inc. - Form 483, 2022-03-30
December, 2021 FDA 483 Aurolife Pharma LLC - Form 483, 2021-12-07
April, 2018 FDA 483 Response Mylan Pharmaceuticals Inc. - Form 483R, 2018-05-03
February, 2022 FDA 483 Response Guardian Drug Company - Form 483R, 2022-02-17
September, 2021 FDA 483 Paramesh Banerji Life Sciences LLC - Form 483, 2021-09-24
January, 2023 FDA 483 PEL HEALTHCARE LLC - Form 483, 2023-01-13
August, 2018 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2018-08-30
April, 2015 EIR WuXi Advanced Therapies Inc. - EIR, 2015-04-17
May, 2022 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2022-05-17
March, 2022 FDA 483 SAMJAN GROUP INC. (DBA PLS Analytical) - Form 483, 2022-03-03
February, 2022 EIR Guardian Drug Company - EIR, 2022-02-17
November, 2017 FDA 483 Pharmaceutics International, Inc. - Form 483, 2017-11-16
May, 2017 EIR Pharmaceutical Manufacturing Research Services, Inc. - EIR, 2017-05-25
August, 2021 FDA 483 Coupler LLC - Form 483, 2021-08-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more